Middle East and Africa ECG Telemetry Device Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Resting ECG Devices, Stress ECG Devices, and Others); End User (Home Healthcare, and Hospitals)

Resting ECG Devices Segment has the Largest Share of Product in the Middle East and Africa ECG Telemetry Device Market during 2021-2028

According to a new market research study on “Middle East and Africa ECG Telemetry Device Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Product, and End-user,” is expected to reach US$ 213.8 million by 2028 from US$ 148.0 million in 2021. The market is estimated to grow at a CAGR of 5.4% from 2021 to 2028. The report provides trends prevailing in the Middle East and Africa ECG telemetry device market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increase in cardiovascular disease incidence and a surge in geriatric population are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the high cost and disadvantages of ECG telemetry devices.

The ECG telemetry devices market in the Middle East and Africa comprises UAE, Saudi Arabia, South Africa, and other GCC. The COVID-19 pandemic has become the most significant challenge in the region. The Middle East has reported around 12 million cases while Africa witnessed 4.5 million cases. Many countries in the region have very less developed and underfunded healthcare systems. Sudden emergence of the virus caused severe pressure on healthcare facilities in the region. Furthermore, shortage of hospital supplies also accelerate the criticality of the condition. During the pandemic, the focus of healthcare professionals was only limited to the COVID management, which substantially hampered the number of other diagnostic procedures and elective surgeries in the region. Moreover, implementation of social distancing policies resulted into limited patients visits to cardiac centers, which drastically impacted the demand and adoption of ECG telemetry devices in Middle East and Africa. Apart from this, a huge population already face a growing burden of non-communicable diseases, making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and have been unable to implement any public health measures and Iran was in deep economic recession due to the US sanctions. Such factors are restraining the growth of the market in the region. However, launch of coronavirus vaccination programs in several countries will ultimately control the situation in years to come. These efforts to control the spread will ultimately recover and restore the situations post-pandemic.

The market for ECG telemetry device market is segmented into product, and End-user. Based on product, the ECG telemetry devices market is segmented into resting ECG devices, stress ECG devices, and others. In 2020, the resting ECG devices by product segment accounted for the highest share of the market and is expected to grow faster during the forecast period. Growth of this segment is attributed as it helps to measures the electrical activity of the heart with no extra preparation required, and it takes about 5 minutes to perform. These tests offers benefits such as it is most simple, quick, and painless, and they can also help to detect heart conditions such as hypertrophy of the heart, myocardial infarction, ischemia, sequelae of myocardial infarction, cardiac arrhythmias, and among others. Additionally, resting ECG is also used as secure and connected workflows to provide accurate solutions that help to reduce complexity and shorten the path to diagnosis.

Cardiac Science Corporation, GE Healthcare Inc. Medtronic Inc. Mindray Medical International Ltd. Nihon Kohden Corporation, Philips Healthcare, Dragger, and Welch Allyn Inc are among the leading companies in the Middle East and Africa ECG telemetry device market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2020, Royal Philips a global leader in health technology, has acquired BioTelemetry, Inc the acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions.

The report segments the Middle East and Africa ECG Telemetry Device market as follows:

By Product

• Resting ECG Devices
• Stress ECG Devices
• Others

By End-user

• Home Healthcare
• Hospitals

By Country

• Middle East and Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA automotive lead acid battery market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the MEA automotive lead acid battery market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the automotive lead acid battery market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution